|
A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma.
|
18006766
|
Clin. Cancer Res.
|
|
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
|
11429699
|
Oncogene
|
|
An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome.
|
16931588
|
J Mol Diagn
|
|
Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3 cell proliferation and anchorage-independent growth.
|
16565507
|
Am. J. Pathol.
|
|
Assessment of gene promoter hypermethylation for detection of cervical neoplasia.
|
16736496
|
Int. J. Cancer
|
|
Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung.
|
11745231
|
Cancer
|
|
DCC promoter hypermethylation in esophageal squamous cell carcinoma.
|
18302152
|
Int. J. Cancer
|
|
Death-associated protein kinase promoter hypermethylation in normal human lymphocytes.
|
14633692
|
Cancer Res.
|
|
Decreased mitochondrial DNA content in posttreatment salivary rinses from head and neck cancer patients.
|
16533782
|
Clin. Cancer Res.
|
|
Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
|
17018594
|
Cancer Res.
|
|
Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study.
|
15192122
|
Mol. Cancer Res.
|
|
Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
|
16908936
|
J. Clin. Oncol.
|
|
Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients.
|
14999140
|
Breast Cancer Res. Treat.
|
|
Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates.
|
11606403
|
Cancer Res.
|
|
Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer.
|
15073103
|
Clin. Cancer Res.
|
|
Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer.
|
16263813
|
J. Clin. Endocrinol. Metab.
|
|
Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer.
|
15814621
|
Clin. Cancer Res.
|
|
Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
|
17020408
|
PLoS Med.
|
|
Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations.
|
12578990
|
Proc. Natl. Acad. Sci. U.S.A.
|
|
Endothelin B receptor gene hypermethylation in prostate adenocarcinoma.
|
12499435
|
J. Clin. Pathol.
|
|
Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer.
|
17534889
|
Int. J. Cancer
|
|
Epigenetic silencing of human T (brachyury homologue) gene in non-small-cell lung cancer.
|
17980147
|
Biochem. Biophys. Res. Commun.
|
|
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
|
18172258
|
Clin. Cancer Res.
|
|
Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck.
|
17456604
|
Proc. Natl. Acad. Sci. U.S.A.
|
|
Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
|
15812243
|
DNA Cell Biol.
|
|
Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
|
12684406
|
Clin. Cancer Res.
|
|
Genome-wide promoter analysis uncovers portions of the cancer methylome.
|
18413733
|
Cancer Res.
|
|
High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.
|
17947477
|
Clin Cancer Res
|
|
HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
|
18234960
|
Mol. Cancer Res.
|
|
Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
|
17016690
|
J. Mol. Med.
|
|
Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis.
|
12727855
|
Cancer Res.
|
|
I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
|
12010858
|
Cancer Epidemiol. Biomarkers Prev.
|
|
Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors.
|
11585726
|
Cancer Res.
|
|
Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer.
|
17118488
|
Lung Cancer
|
|
Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
|
11280771
|
Cancer Res.
|
|
Increased mitochondrial DNA content in saliva associated with head and neck cancer.
|
15814624
|
Clin. Cancer Res.
|
|
Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
|
17360030
|
Gynecol. Oncol.
|
|
Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing.
|
15342377
|
Cancer Res.
|
|
LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer.
|
16912160
|
Cancer Res.
|
|
Loss of chromosome arms 3p and 9p and inactivation of P16 (INK4a) in normal epithelium of patients with primary lung cancer.
|
11550279
|
Genes Chromosomes Cancer
|
|
Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
|
15753360
|
Cancer Res.
|
|
LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer.
|
17456585
|
Cancer Res.
|
|
Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing.
|
12727856
|
Cancer Res.
|
|
Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissues.
|
11448537
|
Cancer Lett.
|
|
Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation.
|
12114429
|
Clin. Cancer Res.
|
|
Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer.
|
18245469
|
Cancer Res.
|
|
Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma.
|
11839667
|
Clin. Cancer Res.
|
|
Mitochondrial DNA alterations in thyroid cancer.
|
12619060
|
J Surg Oncol
|
|
Mitochondrial DNA as a cancer biomarker.
|
15858150
|
J Mol Diagn
|
|
Mitochondrial DNA content increase in response to cigarette smoking.
|
16434581
|
Cancer Epidemiol. Biomarkers Prev.
|
|
Mitochondrial DNA mutations in human cancer.
|
16892080
|
Oncogene
|
|
Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer.
|
17166268
|
Mol. Cancer
|
|
Mitochondrial mutations in early stage prostate cancer and bodily fluids.
|
11526508
|
Oncogene
|
|
Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer.
|
18094415
|
Clin. Cancer Res.
|
|
Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.
|
11882817
|
J. Thorac. Cardiovasc. Surg.
|
|
Molecular characteristics of non-small cell lung cancer.
|
11752463
|
Proc. Natl. Acad. Sci. U.S.A.
|
|
Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
|
11555585
|
Clin. Cancer Res.
|
|
Molecular margin analysis predicts local recurrence after sublobar resection of lung cancer.
|
15515012
|
Int. J. Cancer
|
|
MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
|
15894685
|
Cancer Epidemiol. Biomarkers Prev.
|
|
Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer.
|
11410508
|
Clin. Cancer Res.
|
|
O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer.
|
11719438
|
Cancer Res.
|
|
Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma.
|
15328191
|
Clin. Cancer Res.
|
|
Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma.
|
15328191
|
Clin Cancer Res
|
|
Oxidized guanine lesions and hOgg1 activity in lung cancer.
|
15856018
|
Oncogene
|
|
p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.
|
12837832
|
J. Natl. Cancer Inst.
|
|
PGP9.5 methylation in diffuse-type gastric cancer.
|
16585221
|
Cancer Res.
|
|
PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
|
15930319
|
Cancer Res.
|
|
Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
|
17592394
|
Laryngoscope
|
|
Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
|
16322291
|
Clin. Cancer Res.
|
|
Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
|
11448914
|
Clin. Cancer Res.
|
|
Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
|
11221887
|
Cancer Res.
|
|
Proteomic analysis of cancer-cell mitochondria.
|
14570046
|
Nat. Rev. Cancer
|
|
Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.
|
11717336
|
J. Natl. Cancer Inst.
|
|
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
|
16849682
|
J. Natl. Cancer Inst.
|
|
Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease.
|
11507047
|
Cancer Res.
|
|
Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.
|
11809682
|
Cancer Res.
|
|
Quantitative assessment of promoter methylation profiles in thyroid neoplasms.
|
15840741
|
J. Clin. Endocrinol. Metab.
|
|
Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
|
15289362
|
Cancer Res.
|
|
Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation.
|
17175292
|
Transplant. Proc.
|
|
Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer.
|
12475696
|
Urology
|
|
Quantitative GSTP1 methylation levels correlate with Gleason grade and tumor volume in prostate needle biopsies.
|
15126784
|
J. Urol.
|
|
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies.
|
14600096
|
J. Natl. Cancer Inst.
|
|
Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
|
12576869
|
J. Urol.
|
|
Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.
|
17549626
|
Breast Cancer Res. Treat.
|
|
Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
|
16170165
|
J. Clin. Oncol.
|
|
Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
|
16170165
|
J Clin Oncol
|
|
Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker.
|
15217932
|
Clin. Cancer Res.
|
|
RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma.
|
16619251
|
Int. J. Cancer
|
|
Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations.
|
12917199
|
Cancer Epidemiol. Biomarkers Prev.
|
|
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial.
|
17405999
|
J. Natl. Cancer Inst.
|
|
Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from 2-methoxyestradiol-induced-mitochondria-dependent apoptosis.
|
18246124
|
Oncogene
|
|
Targeting of mutant hogg1 in mammalian mitochondria and nucleus: effect on cellular survival upon oxidative stress.
|
17018150
|
BMC Cancer
|
|
The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection.
|
15123581
|
Genome Res.
|
|
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
|
16862168
|
Oncogene
|
|
Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer.
|
18082200
|
J. Urol.
|
